Comparative outcomes of transcatheter aortic valve replacement in bicuspid vs. tricuspid aortic valve stenosis patients: insights from the SWEDEHEART registry
TAVR in BAV patients yields similar mortality and hemodynamic outcomes as in TAV patients. However, BAVs are associated with lower device success and higher pacemaker rates. While TAVR is a viable alternative to SAVR, treatment should be individualized, especially in younger BAV patients, considering lifetime management and coronary access.
Authors
- Sebastian Völz (ORCID: https://orcid.org/0000-0002-9609-5360)
- Henrik Hagström
- Dan Ioanes (ORCID: https://orcid.org/0000-0002-9953-7726)
- Truls Råmunddal (ORCID: https://orcid.org/0000-0001-9483-5962)
- Anna Myredal (ORCID: https://orcid.org/0000-0002-5179-1506)
- Kristofer Skoglund (ORCID: https://orcid.org/0000-0002-9095-1218)
- Magnus Settergren (ORCID: https://orcid.org/0000-0001-7731-6730)
- Pétur Pétursson (ORCID: https://orcid.org/0000-0003-0807-9406)
- Stefan James
- Johan Sundström (ORCID: https://orcid.org/0000-0003-2247-8454)
- Oskar Angerås (ORCID: https://orcid.org/0000-0002-3474-2438)
- Araz Rawshani (ORCID: https://orcid.org/0000-0003-2066-3533)
- Antros Louca (ORCID: https://orcid.org/0009-0003-7699-593X)
- Sasha M. Koul (ORCID: https://orcid.org/0009-0009-8408-8698)
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Sahlgrenska University Hospital (SE)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101705
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Riksförbundet HjärtLung
- Hjärt-Lungfonden
- Göteborgs Läkaresällskap